A multicenter, open label Phase IIIb study of subcutaneously administered Raptiva in the treatment of adult patients with moderate to severe plaque psoriasis.

Journal of Drugs in DermatologyVol. 5 Nbr. 3, March 2006

Linked as:

Summary


CLINICAL TRIAL REVIEW

See the full content of this document

Extract


A multicenter, open label Phase IIIb study of subcutaneously administered Raptiva in the treatment of adult patients with moderate to severe plaque psoriasis.

This study is currentl...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company